OBJECTIVES: Patent ductus arteriosus (PDA) remains a challenging issue in very low birth
weight (VLBW) infants, and its management varies widely. Our aim in this study was to …

Objective The persistence of the patent ductus arteriosus (PDA) is frequently encountered in
very preterm infants. Neither preventive nor curative treatments of PDA have been shown to …

OBJECTIVE: To examine yearly trends of patent ductus arteriosus (PDA) diagnosis and
treatment in very low birth weight infants. METHODS: In this retrospective cohort study of …

Objective To determine whether a nonintervention approach for treating hemodynamically
significant patent ductus arteriosus (PDA) is associated with decreased mortality and/or …

Background: A patent ductus arteriosus (PDA) is common among preterms, and prophylactic
medical treatment has been advocated as the first-line approach. Conservative treatment …

Background Patent ductus arteriosus (PDA) is common in extremely low birth weight (ELBW)
infants. The objectives of this study were to describe our early clinical experience of …

Background Treatment of the patent ductus arteriosus (PDA) in the preterm infant remains
contentious. There are numerous options of the PDA management from early targeted …

This study aimed to determine the natural course of patent ductus arteriosus (PDA) with
noninterventional conservative management and whether the presence and/or prolonged …

Background Percutaneous closure of patent ductus arteriosus (PDA) in term neonates is
established, but data regarding outcomes in infants born very preterm (< 32 weeks of …

OBJECTIVE. Because the standard of care has been to attempt to close the patent ductus
arteriosus in preterm neonates, there is a paucity of information on the outcome of patients …